Press Releases

HAVN Life Ships First White Label Order to Distribution Partner Woke Pharmaceuticals in Australia

The successful shipment of white label natural health products will expand the Company’s global retail footprint Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce it …

HAVN Life Ships First White Label Order to Distribution Partner Woke Pharmaceuticals in Australia Read More »

HAVN Life Launches the Brain Evolve Series

The four formulations, helping to reduce inflammation, promote restorative sleep and support cognitive function are now available on yourhavnlife.com Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company developing natural health products and innovative therapies to support brain health and cognitive function, is …

HAVN Life Launches the Brain Evolve Series Read More »

HAVN Life Expands Supply Agreement with Mycotopia Therapies Inc.

The expanded partnership to include the distribution of functional mushrooms, HAVN Life natural health products and white label products, in addition to its naturally-derived psilocybin compounds Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the …

HAVN Life Expands Supply Agreement with Mycotopia Therapies Inc. Read More »

HAVN Life Announces Distribution Deal with Jonluca Enterprises Inc.

With this deal, The Company’s full line of natural health formulations will now be available across Canada at select health food store locations Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural …

HAVN Life Announces Distribution Deal with Jonluca Enterprises Inc. Read More »

HAVN Life Closes C$2,000,000 Private Placement with U.S. Institutional Investors

Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company developing natural health products and innovative therapies to support brain health and cognitive function, is pleased to announce that it has closed its previously announced sale of units to U.S. institutional investors, for gross …

HAVN Life Closes C$2,000,000 Private Placement with U.S. Institutional Investors Read More »

HAVN Life Announces Retail Partnership with Alberta Grocer, Calgary Co-op

The Company’s full line of natural health formulations will be available at select locations starting in May Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychoactive compounds and the development of natural health products, is pleased to announce …

HAVN Life Announces Retail Partnership with Alberta Grocer, Calgary Co-op Read More »

HAVN Life To Present at Upcoming Emerging Growth Conference 26

CEO Tim Moore will share recent partnership and distribution news and a roadmap for the Company’s plans for the next quarter Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support …

HAVN Life To Present at Upcoming Emerging Growth Conference 26 Read More »

HAVN Life at Q1 2022 Virtual Investor Summit

CEO Tim Moore will join 80+ other small cap and micro cap companies at leading investor event Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company pursuing standardized extraction of psychedelic compounds for the creation of APIs that support brain health and cognitive …

HAVN Life at Q1 2022 Virtual Investor Summit Read More »

HAVN Life Natural Health Products Now Available on Amazon.com

The Company continues to grow its global retail footprint by partnering with the world’s largest ecommerce site Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”), a biotechnology company developing natural health products and innovative therapies to support brain health and cognitive function, is pleased to …

HAVN Life Natural Health Products Now Available on Amazon.com Read More »

HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research

The naturally derived GMP psilocybin will be exported through distribution partner Mycrodose Therapeutics Inc. to the University of Wisconsin-Madison, Contract Research Organization for Revive Therapeutics Vancouver, BC – Havn Life Sciences Inc. (CSE: HAVN) (OTC: HAVLF) (FSE: 5NP) (the “Company” or “HAVN Life”) a biotechnology company pursuing standardized extraction of psychedelic compounds for investigational research …

HAVN Life Secures Purchase Order for Controlled Substance Sale to Revive Therapeutics Ltd. for Use in Clinical Research Read More »

Scroll to Top